Restoration of sagittal alignment in high-grade isthmic spondylolisthesis using the reverse Bohlman technique with anterior lumbar interbody fusion using a hyperlordotic cage at L4-5: illustrative case

Case Reports

. 2021 Jun 28;1(26):CASE208.


doi: 10.3171/CASE208.

Affiliations

Item in Clipboard

Case Reports

Terrence Ishmael et al.


J Neurosurg Case Lessons.


.

Abstract


Background:

Circumferential fusion with or without reduction is the preferred treatment for high-grade isthmic spondylolisthesis. Reduction presents significant risk of neurological injury. The authors present one case in which the “reverse Bohlman” technique was used with the addition of a hyperlordotic interbody cage at L4-5 as a means to correct sagittal malalignment while avoiding the reduction of L5 on S1.


Observations:

The patient was a 22-year-old woman with a long-term history of lower back pain and bilateral L5 radiculopathy secondary to high-grade isthmic lumbar spondylolisthesis. She underwent anterior lumbar interbody fusion using the reverse Bohlman technique plus a hyperlordotic interbody cage at L4-5, followed by decompression and posterior spinal instrumentation and fusion from L4 to the pelvis. At 2-year follow-up, she was found to have complete resolution of symptoms with clinical and radiographic evidence of fusion. Her spinopelvic parameters had significantly improved.


Lessons:

The reverse Bohlman technique with the addition of a hyperlordotic interbody cage at L4-5 is a potential alternative treatment method to correct sagittal malalignment while avoiding possible injury to the L5 nerve roots that can be seen in the reduction of high-grade isthmic spondylolisthesis.


Keywords:

ALIF; ALIF = anterior lumbar interbody fusion; BMI = body mass index; CT = computed tomography; MRI = magnetic resonance imaging; SVA = sagittal vertical axis; TLIF = transforaminal lumbar interbody fusion; anterior lumbar interbody fusion; high-grade spondylolisthesis; hyperlordotic.

Conflict of interest statement

Disclosures Dr. Arlet reports receiving personal fees from DePuy Synthes, Zimmer Biomet, and NuVasive.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on vk
VK
Share on pinterest
Pinterest
Close Menu